Skip to main content

Advertisement

Log in

Comparison of existing disease activity indices in the follow-up of patients with Behçet’s disease

  • Original Article
  • Published:
Modern Rheumatology

Abstract

The objective of this study was to determine the concordance between the Iranian Behçet’s disease dynamic activity measure (IBDDAM) or the Behçet’s disease current activity form (BDCAF) and expert physician global assessment (PGA) in the evaluation of disease activity changes in Behçet’s disease (BD). In a prospective study, 117 consecutive patients with BD were evaluated in their two consecutive follow-up visits by IBDDAM and BDCAF. The change in disease activity was determined (increased, unchanged or decreased) according to the PGA. We used receiver operating characteristic (ROC) curve to determine an appropriate cutoff point for disease activity change. Comparison was made by Stata and kappa analysis. Comparing the area under the ROC curve showed a significant difference between IBDDAM and BDCAF (p < 0.03). The difference was more significant between nonocular IBDDAM and BDCAF (p < 0.002). Better concordance was also observed for IBDDAM (nonocular and total) with PGA than BDCAF. The difference was not significant for ocular IBDDAM. The best cutoff point for nonocular IBDDAM was 0.45, for ocular IBDDAM was 3.5, and for BDCAF was 1 point. IBDDAM was the preferred method for the evaluation of disease activity change in patients with BD (without ocular involvement) considering a change of at least 0.45.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341:1284–91.

    Article  PubMed  CAS  Google Scholar 

  2. Davatchi F. Behçet’s disease. In: Howe HS, Feng PH, editors. Textbook of clinical rheumatology. Singapore: National Arthritis Foundation; 1998. p. 298–315.

    Google Scholar 

  3. Chamberlain M, Noble B, Behçet’s U.K. Study Group. Disease activity in Behçet’s disease. In: O’Duffy J, Kokmen E, editors. Behçet’s disease. Basic and clinical aspects. New York: Marcel Dekker; 1991. p. 299–302.

    Google Scholar 

  4. Jamshidi A, Shahram F, Akbarian M, Gharibdoost F, Nadji A, Chams C, et al. The accuracy of IBDDAM (Iran Behçet’s disease dynamic activity measure) in the treatment evaluation of Behçet’s disease. APLAR J Rheumatol. 2001;4:161–3.

    Google Scholar 

  5. Hamuryudan V, Fresko I, Direskeneli H, Tenant M, Yurdakul S, Akoglu T, et al. Evaluation of the Turkish translation of a disease activity form for Behçet’s syndrome. Rheumatology. 1999;38:734–6.

    Article  PubMed  CAS  Google Scholar 

  6. Muftuoglu A, Yazici H, Yurdakul S, Tuzun Y, Pazarli H, Gungen G, et al. Behçet’s disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol. 1986;25:235–9.

    Article  PubMed  CAS  Google Scholar 

  7. Bhakta B, Brennan P, James T, Chamberlain M, Noble B, Silman A. Behçet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology. 1999;38:728–33.

    Article  PubMed  CAS  Google Scholar 

  8. Lawton G, Bhakta B, Chamberlain M, Tennant A. The Behçet’s disease activity index. Rheumatology. 2004;43:73–8.

    Article  PubMed  CAS  Google Scholar 

  9. Baltaci M. A review on disease activity scores in Behçet’s disease. Arthritis Res Ther. 2003;5(Suppl 2):7.

    Article  Google Scholar 

  10. Davatchi F, Akbarian M, Shahram F, Tebbi M, Chams C, Chams H. Iran Behçet’s disease dynamic activity measure. Abstracts of the XIIth European congress of rheumatology. Hungarian Rheumatol. 1991;32:134 (abstract FP10–100).

    Google Scholar 

  11. Bhakta B, Hamuryudan V, Brennan P, Chamberlain M, Barnes C, Silman A. Assessment of disease activity in Behçet’s disease. In: Wechsler B, Godeau P, editors. Excerpta medica international congress series, 1037, 611. Amsterdam: Elsevier Science; 1993. p. 235–40.

    Google Scholar 

  12. International Study Group for Behçet’s disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–80.

    Google Scholar 

  13. Chamberlain M, Bhakta B, Tennant A, Eyres S. Behçet’s disease: diagnosis and assessment of disease activity. In: Bang D, Lee E, Lee S, editors. Behçet’s disease. Seoul: Design Mecca; 2000. p. 105–9.

    Google Scholar 

  14. Dinc A, Erdem H. IBDDAM vs. Leeds scoring to measure disease activity in Behçet’s patients. In: 10th International conference on Behçet’s disease, June 2002, Berlin, Germany. Programme and abstracts: p. 59 (Abstract 010).

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Farhad Shahram.

About this article

Cite this article

Shahram, F., Khabbazi, A., Nadji, A. et al. Comparison of existing disease activity indices in the follow-up of patients with Behçet’s disease. Mod Rheumatol 19, 536–541 (2009). https://doi.org/10.1007/s10165-009-0191-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-009-0191-z

Keywords

Navigation